Published in Nature Communications · View the paper (DOI)
Researchers have developed a novel vaccine that protects against both Lassa fever and rabies, with promising results in preclinical testing. The vaccine, called LASSARAB, uses a weakened rabies virus vector to elicit an immune response against both viruses.
Coverage from 2 institutions